| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.15▼ | 1.15▼ | 1.15▼ | 1.13▲ | 1.00▲ |
| MA10 | 1.15▼ | 1.14▲ | 1.13▲ | 1.02▲ | 1.06▲ |
| MA20 | 1.13▲ | 1.12▲ | 1.11▲ | 0.99▲ | 1.01▲ |
| MA50 | 1.10▲ | 1.01▲ | 1.00▲ | 1.07▲ | 1.03▲ |
| MA100 | 0.99▲ | 1.01▲ | 1.02▲ | 1.01▲ | 1.08▲ |
| MA200 | 1.01▲ | 1.09▲ | 1.08▲ | 1.00▲ | 1.98▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.001▼ | -0.003▼ | -0.001▼ | 0.030▲ | 0.003▲ |
| RSI | 62.542▲ | 65.338▲ | 66.271▲ | 59.358▲ | 55.668▲ |
| STOCH | 56.667 | 91.647▲ | 91.117▲ | 80.499▲ | 36.296 |
| WILL %R | -33.333 | -14.286▲ | -14.286▲ | -16.756▲ | -39.670 |
| CCI | 3.318 | 51.852 | 69.058 | 116.490▲ | 69.760 |
| ▲ MACD | $CTSO MACD(12,26,9) Crossed Above Zero | Set Alert |
|
Wednesday, August 13, 2025 01:23 PM
CTSO READ THE FULL CTSO RESEARCH REPORT 2nd Quarter 2025 Financial & Operating Results On August 7, 2025, CytoSorbents (NASDAQ:CTSO) reported 2nd quarter 2025 financial and operating results which ...
|
|
Sunday, August 10, 2025 05:59 AM
Second Quarter 2025 Results Key Financial Results Revenue: US$9.62m (down 2.8% from ...
|
|
Friday, August 08, 2025 10:23 AM
Discover how Cytosorbents Corporation achieved 9% Q2 sales growth and navigates regulatory challenges for DrugSorb ATR.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 15/08/25 | 1.13 | 1.16 | 1.13 | 1.145 | 38,372 |
| 14/08/25 | 1.08 | 1.14 | 1.03 | 1.14 | 77,892 |
| 13/08/25 | 1.05 | 1.095 | 1.04 | 1.08 | 52,259 |
| 12/08/25 | 1.15 | 1.179 | 1.06 | 1.06 | 171,525 |
| 11/08/25 | 1.02 | 1.22 | 1.01 | 1.20 | 318,445 |
| 08/08/25 | 0.9394 | 1.0066 | 0.9095 | 1.00 | 98,412 |
| 07/08/25 | 0.902 | 0.93 | 0.8932 | 0.8932 | 79,585 |
| 06/08/25 | 0.911 | 0.9399 | 0.8754 | 0.902 | 72,590 |
| 05/08/25 | 0.8921 | 0.9387 | 0.8723 | 0.915 | 52,450 |
| 04/08/25 | 0.90 | 0.9111 | 0.8413 | 0.9111 | 218,869 |
|
|
||||
|
|
||||
|
|